Top Markets
#1 Black Phoenix Black Phoenix +166.51%
#2 Islamic Coin Islamic Coin +158.21%
#3 Glidr Glidr +58.56%
#4 Cryptopia Cryptopia +20.30%
#5 DOVU DOVU +19.60%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.07%
#7 Test Test +11.85%
#8 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +11.57%
#9 MarsCoin MarsCoin +10.95%
#10 stake.link stake.link +8.58%
Coin of the day
Black Phoenix Black Phoenix
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Q BioMed Inc. Q BioMed Inc.

Q BioMed Inc.

QBIO
Clasificación en acciones #41615
Q BioMed Inc. functions as a biomedical accelerator and developer, actively... Q BioMed Inc. functions as a biomedical accelerator and developer, actively licensing, acquiring, and supplying resources to firms within the life sciences and healthcare sectors. Its commercial portfolio includes Metastron (Strontium Chloride SR89), a radiopharmaceutical designed to alleviate pain associated with metastatic bone cancer. Additionally, Q BioMed is advancing a pipeline of therapeutic candidates, including Man-01, a pre-clinical compound aimed at primary open-angle glaucoma; QBM-001, intended for rare pediatric non-verbal autism spectrum disorder; and Uttroside-B, which targets liver cancer. The company also collaborates with Mannin Research Inc. on the development of treatments for conditions such as acute respiratory distress syndrome, glaucoma, and various kidney diseases. Incorporated in New York, New York, in 2013, the entity was initially named ISMO Tech Solutions, Inc. before adopting its current name, Q BioMed Inc., in July 2015.
Precio por acción
$0.0001
Última sincronización: 2026-04-02
Capitalización bursátil
$14.51K
Cambio (1 día)
0.00%
Cambio (1 año)
9,900.00%
País
US
Comercio Q BioMed Inc. (QBIO)

Categoría

Healthcare
Ingresos de Q BioMed Inc. (QBIO)
Ingresos en Aug 2026 TTM: 0
Según los últimos informes financieros de Q BioMed Inc., los ingresos actuales de la empresa (TTM) son 0. En 2026, la empresa obtuvo unos ingresos de 0 igual a los ingresos del año 2026, que fueron de 0. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de Q BioMed Inc. desde 2026 hasta 2026
Ingresos al final de cada año
Año Ingresos Cambiar
Not enough data for the provided dates.
Ingresos de empresas similares o competidoras
Empresa Ingresos Diferencia de ingresos País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR